Patent ID: 8694073
Filing Date: 2014-04-08
Classification: A61B

Abstract:
1. A method for determining, in a patient that has a mood disorder, an expectation of the patient to manifest a reduced severity of the mood disorder in response to a treatment modality, the method comprising: determining, in a patient that has a mood disorder, a first baseline level of a metabolic marker in the patient's brain; comparing, by a processor, the first baseline level to a second, stored baseline level of the marker, the second baseline level comprising a value or a range of values of the marker in the brain of at least one subject that, while having the mood disorder, was exposed to the treatment modality and was responsive or not responsive to the treatment modality; determining, by a processor and based on a difference between the first baseline level and the second baseline level, a classification of the patient as likely to be either a treatment responder or a treatment nonresponder; and outputting, by a processor, an indicator of the classification to an output device.